22nd Century Group Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
XXII Nasdaq 8731 https://www.xxiicentury.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for 22nd Century Group Inc

22nd Century Group (XXII) Launching VLN® at #1 U.S. C-Store Chain in Texas, California and Florida - Jun 6th, 2023 1:00 pm
22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII - Jun 2nd, 2023 12:30 pm
22nd Century Group (XXII) Highlights Recent TCORS Symposium Findings - May 25th, 2023 1:00 pm
22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook - May 9th, 2023 10:00 am
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023 - May 3rd, 2023 1:15 pm
22nd Century Group (XXII) Announces Strategic License, Manufacturing and Distribution Agreement with Old Pal - May 2nd, 2023 1:15 pm
22nd Century Group Launches New Private Label Brand with Top U.S. C-Store Chain - Apr 18th, 2023 11:00 am
22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies - Apr 5th, 2023 12:30 pm
22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update - Mar 9th, 2023 11:00 am
22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives - Mar 3rd, 2023 9:05 pm
22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference - Mar 2nd, 2023 9:15 pm
22nd Century Group (Nasdaq: XXII) to Announce Fourth Quarter and Full Year 2022 Results on March 9, 2023 - Feb 23rd, 2023 2:00 pm
22nd Century Group (XXII) Accelerates Major Growing Program to Enable Implementation of New Zealand’s Reduced-Nicotine Content Tobacco Law - Feb 22nd, 2023 2:00 pm
Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That “Helps You Smoke Less” - Feb 7th, 2023 2:00 pm
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position - Jan 24th, 2023 2:20 pm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Jan 24th, 2023 2:33 am
22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs - Jan 23rd, 2023 2:20 pm
22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown - Jan 18th, 2023 2:25 pm
FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers - Jan 17th, 2023 2:00 pm
In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews John Miller President, 22nd Century Group Inc. - Dec 16th, 2022 1:05 pm